Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: Analysis of Gynecologic Oncology Group Trials
Antineoplastic Combined Chemotherapy Protocols
Health Status Disparities
When they received similar treatment, there was no difference in clinical outcome between black women and white women with advanced stage epithelial ovarian cancer when they received similar treatment as participants in Gynecologic Oncology Group clinical trials. Black patients may experience less severe gastrointestinal toxicity or leukopenia compared with whites when treated with platinum-based chemotherapy.